PATENT CLAIM ANALYSIS

Application Number: 15889261
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "009800"]

Abstract:
Disclosed herein is a method of identifying and/or addressing incipient preeclampsia in a patient-subject by the steps of (a) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a said patient-subject at about 25 weeks of pregnancy or earlier; (b) performing a bioassay to determine the level of at least one sialyl Lewis antigen in a pregnant non-preeclampsia one or more subjects at about 30 weeks of pregnancy or later, wherein said at least one sialyl Lewis antigen assay is for a sialyl Lewis antigen assayed in step (a) is and if more than one subject is assayed, averaging said results; and (c) managing said patient-subject for preeclampsia, if said level of at least one sialyl Lewis antigen of step (a) is at or greater than about 20% above the level of such silalyl Lewis antigen assayed in step (b).

Claim (Index 17):
The method of  claim 1 , wherein in step (c), levels of the at least one sialyl Lewis antigen are determined in two or more pregnant non-preeclampsia subjects, the levels are averaged.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 88.0
- Lexical Diversity: 2.53846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11131952', '12698395', '11317378', '13180845', '12849651']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7762963667507118
- 35 USC 102 Novelty (BERT): 0.5079758790013881
- Combined Prediction Score: 0.7494643179757794
- Mean Citation Score: 233.228884
- Max Citation Score: 239.21918
- Similarity Product: 151.36429036332606

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test